Markets:

Overview

News

Currencies

International

Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

748.71 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Regeneron Pharmaceuticals

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

58 59 Next >

If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names ↗

July 26, 2023

These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.

Via InvestorPlace

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List ↗

July 26, 2023

The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 ↗

July 24, 2023

These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful.

Via InvestorPlace

Why Are Kodiak Sciences Shares Trading Lower Today? ↗

July 24, 2023

Kodiak Sciences Inc (NASDAQ: KOD) shares are tumbling after the company released topline results from three Phase 3 studies of tarcocimab tedromer, a novel antibody biopolymer conjugate, for...

Via Benzinga

Looking Into Regeneron Pharmaceuticals's Recent Short Interest ↗

July 19, 2023

Via Benzinga

This Is What Whales Are Betting On Regeneron Pharmaceuticals ↗

July 17, 2023

Via Benzinga

$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today ↗

July 11, 2023

Via Benzinga

Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity ↗

July 07, 2023

Via Benzinga

Is Regeneron Stock a Buy After a Regulatory Blow? ↗

July 07, 2023

Don't write this company's eulogy too fast.

Via The Motley Fool

Alnylam Says Single Injection Of RNAi Therapy Cuts Alzheimer's-Linked Proteins By 65%, Stock Soars ↗

July 17, 2023

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced updated interim results for the ongoing single ascending dose portion of the Phase 1 study of ALN-APP for Alzheimer's disease and

Via Benzinga

3 Pharma Stocks That AI is Loving in July ↗

July 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

Via InvestorPlace

3 Biotech Stocks to Buy for Long-Term Gains

July 13, 2023

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.

Via MarketBeat

Topics ETFs Economy

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now ↗

July 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

Via InvestorPlace

Check Out What Whales Are Doing With REGN ↗

July 03, 2023

Via Benzinga

Looking Into Regeneron Pharmaceuticals's Recent Short Interest ↗

July 03, 2023

Via Benzinga

Why Regeneron Pharmaceuticals Stock Dipped This Week ↗

June 29, 2023

A key regulatory setback is weighing on the biotech's stock.

Via The Motley Fool

Check Out What Whales Are Doing With REGN ↗

June 28, 2023

Via Benzinga

Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday ↗

July 06, 2023

Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at...

Via Benzinga

Is Regeneron's Stock in Trouble After This FDA Rejection? ↗

July 06, 2023

The company's growth rate has been slowing sharply in recent quarters, and Eylea generates the bulk of its product revenue.

Via The Motley Fool

$1 Billion Deal For Moderna To Expand Product Pipeline in China

July 06, 2023

Moderna is looking to diversify its falling U.S. product line, a $1 billion investment in China may act as the catalyst pushing the company's valuation higher

Via MarketBeat

Topics ETFs Economy

Biotech Blues: Stay Balanced Through July Earnings Season ↗

July 05, 2023

Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.

Via Talk Markets

The 3 Best Biotech Stocks to Buy In July ↗

July 05, 2023

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

Via InvestorPlace

Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review ↗

June 30, 2023

Major indexes rebounded strongly and many stocks flashed buy signals.

Via Investor's Business Daily

Regeneron to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on August 3, 2023

June 29, 2023

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

What Will Amgen Buy Next? ↗

June 29, 2023

The biotech could pursue these two budget-friendly targets.

Via The Motley Fool

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

June 29, 2023

From The Schall Law Firm

Via Business Wire

Why Catalent Stock Flopped Today ↗

June 28, 2023

The company takes the fall for a failed drug application.

Via The Motley Fool

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

June 28, 2023

From The Schall Law Firm

Via Business Wire

Why Regeneron Stock Is Trading Lower Today ↗

June 28, 2023

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares continue to fall Wednesday after news Tuesday that the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023 ↗

June 28, 2023

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Regeneron Pharmaceuticals (NQ:REGN)

All News about Regeneron Pharmaceuticals

Starting at $3.75/week.

Subscribe Today